Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Greensboro-High Point, NC MSA — September 2026
Greensboro's regulatory pay premium meets a validation pay gap.
Regulatory Affairs Specialist pay in Greensboro has climbed to $119,275 — above the $104,000 national median — while Validation Engineer pay sits flat at $96,700 against a national move to $108,377.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro unemployment rate: 4.0% — vs 3.5% NC, 3.1% Raleigh-Cary (Aug 2026)
- Regulatory Affairs advertised pay: $119,275 — vs $104,000 national median
- Validation Engineer advertised pay: $96,700 — flat locally vs moderate national rise to $108,377
- NC WARN notices, last 90 days: 13 notices / 1,336 workers — Manufacturing and healthcare most affected statewide
Key takeaways
Regulatory Affairs pay has outpaced the national market here.
Metro median advertised pay for Regulatory Affairs Specialists now exceeds the national figure by roughly $15,000, consistent with national reporting that regulatory talent — particularly those with BLA/NDA experience — faces acute scarcity. Leaders should treat this as a structural repricing, not a one-month spike, when setting offers for compliance-to-strategy regulatory hires.
Validation Engineer pay is stagnant while national rates climb.
Metro median has held at $96,700 while the national median moved up moderately to $108,377, widening a gap that may put Greensboro quality and manufacturing-support roles at competitive disadvantage against Triangle-area CDMO and biologics expansion. Flat local pay in a role tied directly to manufacturing scale-up decisions is worth benchmarking against nearby project announcements, not just historical metro data.
Lab Technician pay decline may widen entry-level talent gaps.
Metro median Lab Technician pay fell significantly to $46,055, tracking a national decline but outpacing it, even as BioWork-style credential programs in Wilson County funnel graduates into $67,000 starting manufacturing roles. Greensboro employers competing for the same entry-level pipeline may find falling advertised pay works against them when nearby programs are producing comparably credentialed candidates at higher starting wages.
CRA pay strength signals clinical-function competition is intensifying.
Metro Clinical Research Associate pay rose at a moderate pace to $63,700, still well below the national median of $90,956, a gap that may reflect fewer large clinical-stage sponsors locally but also signals headroom for wage pressure if CRO or sponsor hiring picks up. Build-vs-outsource decisions involving CRO partners should account for the likelihood that local CRA pay converges toward national levels faster than historical patterns suggest.
Median advertised pay by role — Greensboro-High Point, NC MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $103,601 | $123,500 | $136,449 | Moderate increase | $131,354 |
| Clinical Research Associate | $57,403 | $63,700 | $67,922 | Moderate increase | $90,956 |
| Lab Technician | $41,046 | $46,055 | $49,140 | Significant decline | $47,402 |
| Regulatory Affairs Specialist * | $77,989 | $119,275 | $119,887 | Significant increase | $104,000 |
| Clinical Data Manager * | $101,184 | $118,202 | $121,795 | Stable | $123,031 |
| Biostatistician * | $113,295 | $142,332 | $169,605 | Significant increase | $133,322 |
| Validation Engineer * | $90,115 | $96,700 | $108,040 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Greensboro-High Point's 4.0% August unemployment rate sits above both the state's 3.5% and Raleigh-Cary's 3.1%, reflecting manufacturing and transportation-sector softening against a backdrop of regional biomanufacturing expansion concentrated outside the metro in Wilson County and the Triangle. Statewide WARN filings remain healthcare- and manufacturing-heavy even as life sciences employers elsewhere in North Carolina announce thousands of new jobs, leaving Greensboro-area employers competing for specialized scientific talent against better-funded, faster-growing hubs.
What it means
Regulatory Affairs Specialist advertised pay in the metro has climbed to $119,275 median — now running above the national figure of $104,000 — suggesting local employers are bidding aggressively for a function already described as a national bottleneck, while Validation Engineer pay sits flat locally at $96,700 versus a national uptick, a gap that may erode retention leverage for manufacturing-adjacent quality roles as J&J's Wilson County campus and Amgen's Holly Springs expansion pull experienced talent eastward. Current conditions suggest reviewing whether Greensboro's quality and validation compensation structures remain competitive against Triangle-area biomanufacturing employers before those roles become attrition points rather than retention assets.
Looking ahead
Worth watching: NC Life Sciences Organization's September 23 forum raised direct questions about whether the state's biomanufacturing workforce pipeline can keep pace with Amgen, J&J, and other announced expansions. Watch whether Greensboro-area employers see increased poaching pressure as Triangle and Wilson County projects ramp hiring in Q4.
Emerging pressure point: Statewide WARN filings show healthcare and manufacturing among the most-affected sectors, with 13 notices in the last 90 days alone. Monitor whether any Guilford County manufacturing displacement produces qualified quality or validation candidates entering the local life sciences pool.
Potential inflection point: Regulatory Affairs advertised pay already exceeds national levels in this metro — a rare local premium. Track whether this holds through Q4 or reflects a small number of high-paying postings skewing the median, before anchoring new offers to it.
Early indicator: Cell therapy CDMO consolidation activity, including Kincellis Advanced Therapies' recent CSO appointment, suggests contract manufacturers may be stabilizing leadership ahead of broader deal activity. Watch for signals this affects build-vs-outsource economics for Greensboro-area sponsors weighing CDMO partnerships.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.